Advances in MUC1-Mediated Breast Cancer Immunotherapy

Breast cancer (BRCA) is the leading cause of death from malignant tumors among women. Fortunately, however, immunotherapy has recently become a prospective BRCA treatment with encouraging achievements and mild safety profiles. Since the overexpression and aberrant glycosylation of MUC1 (human mucin)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhifeng, Yang, Dazhuang, Guo, Ting, Lin, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313386/
https://www.ncbi.nlm.nih.gov/pubmed/35883508
http://dx.doi.org/10.3390/biom12070952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313386/
https://www.ncbi.nlm.nih.gov/pubmed/35883508
http://dx.doi.org/10.3390/biom12070952

Ejemplares similares